Johnson & Johnson (NYSE:JNJ) announced on Saturday the initial results from a group of patients who were part of its ...

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have ...

By using a compound derived from a Himalayan fungus and used for centuries in Chinese medicine as a jumping off point, ...

U.S. health agencies announced that the food industry will begin "phasing out" eight artificial food dyes in the coming years ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in the U.S.

St. Pete doctor credits “Patient No More Series” for insurer’s change in policy for popular breast cancer surgery.

Waksal, who is not a medical doctor, imported the veterinary drug along with other “unapproved ingredients” from Colombia.

Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

Researchers from Johns Hopkins University have identified three subtypes of senescent skin cells with distinct shapes, ...